Clinical status of diagnosis and therapy of malignant melanoma

F. Belli, M. Santinami, M. T. Baldini, A. Testori, A. Maio, N. Cascinelli

Research output: Contribution to journalArticlepeer-review


We believe that the immunotherapy of melanoma represents a fundamental approach in the treatment of this disease. In this regard the monoclonal antibodies, because of their high specificity, their demonstrated lack of toxicity after repeated injection and the possibility of their use both as direct cytotoxic factors and carriers of other molecules, constitute one of the most intriguing prospectives of therapy of this threatening cancer.

Original languageEnglish
Pages (from-to)621-624
Number of pages4
JournalNuclear Medicine and Biology
Issue number6
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Clinical status of diagnosis and therapy of malignant melanoma'. Together they form a unique fingerprint.

Cite this